Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis. 2001

P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
Division of Diabetes, Department of Medicine, The University of Texas Health Science Center, San Antonio, Texas 78284, USA.

Although chronic hyperinsulinemia has been shown to induce insulin resistance, the basic cellular mechanisms responsible for this phenomenon are unknown. The present study was performed 1) to determine the time-related effect of physiological hyperinsulinemia on glycogen synthase (GS) activity, hexokinase II (HKII) activity and mRNA content, and GLUT-4 protein in muscle from healthy subjects, and 2) to relate hyperinsulinemia-induced alterations in these parameters to changes in glucose metabolism in vivo. Twenty healthy subjects had a 240-min euglycemic insulin clamp study with muscle biopsies and then received a low-dose insulin infusion for 24 (n = 6) or 72 h (n = 14) (plasma insulin concentration = 121 +/- 9 or 143 +/- 25 pmol/l, respectively). During the baseline insulin clamp, GS fractional velocity (0.075 +/- 0.008 to 0.229 +/- 0.02, P < 0.01), HKII mRNA content (0.179 +/- 0.034 to 0.354 +/- 0.087, P < 0.05), and HKII activity (2.41 +/- 0.63 to 3.35 +/- 0.54 pmol x min(-1) x ng(-1), P < 0.05), as well as whole body glucose disposal and nonoxidative glucose disposal, increased. During the insulin clamp performed after 24 and 72 h of sustained physiological hyperinsulinemia, the ability of insulin to increase muscle GS fractional velocity, total body glucose disposal, and nonoxidative glucose disposal was impaired (all P < 0.01), whereas the effect of insulin on muscle HKII mRNA, HKII activity, GLUT-4 protein content, and whole body rates of glucose oxidation and glycolysis remained unchanged. Muscle glycogen concentration did not change [116 +/- 28 vs. 126 +/- 29 micromol/kg muscle, P = nonsignificant (NS)] and was not correlated with the change in nonoxidative glucose disposal (r = 0.074, P = NS). In summary, modest chronic hyperinsulinemia may contribute directly (independent of change in muscle glycogen concentration) to the development of insulin resistance by its impact on the GS pathway.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D009004 Monosaccharide Transport Proteins A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES. Hexose Transport Proteins,Band 4.5 Preactin,Erythrocyte Band 4.5 Protein,Glucose Transport-Inducing Protein,Hexose Transporter,4.5 Preactin, Band,Glucose Transport Inducing Protein,Preactin, Band 4.5,Proteins, Monosaccharide Transport,Transport Proteins, Hexose,Transport Proteins, Monosaccharide,Transport-Inducing Protein, Glucose
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006003 Glycogen

Related Publications

P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
January 2008, Molecular and cellular biology,
P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
July 2010, Archives of physiology and biochemistry,
P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
February 2015, American journal of physiology. Endocrinology and metabolism,
P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
November 1988, The Journal of clinical investigation,
P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
December 2004, Journal of applied physiology (Bethesda, Md. : 1985),
P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
August 1998, The American journal of physiology,
P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
February 1990, The Journal of clinical investigation,
P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
January 1972, Diabetes,
P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
September 2017, Diabetes,
P Iozzo, and T Pratipanawatr, and H Pijl, and C Vogt, and V Kumar, and R Pipek, and M Matsuda, and L J Mandarino, and K J Cusi, and R A DeFronzo
September 1997, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!